This site is intended for healthcare professionals
  • Home
  • /
  • Journals
  • /
  • Leukaemia
  • /
  • Clinical considerations for the use of FLT3 inhibi...

Clinical considerations for the use of FLT3 inhibitors in acute myeloid leukemia.

Read time: 1 mins
Published:1st Sep 2019
Author: Weis TM, Marini BL, Bixby DL, Perissinotti AJ.
Availability: Pay for access, or by subscription
Ref.:Crit Rev Oncol Hematol. 2019;141:125-138.
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest